Elutia Inc.
ELUTHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, Elutia Inc. (ELUT) is listed under Medical Devices. Valued at $37.1M, ELUT is a micro-cap name in its sector. The company operates in two segments, Women's Health and Cardiovascular.
Market Cap
$37.1M
Beta
0.84
P/E (TTM)
—
P/E (Fwd)
-0.76
EPS (TTM)
$-0.64
EPS (Fwd)
$-1.10
ROE
—
ROA
-34.7%
Cash
$19.9M
Total Debt
$4.4M
Free CF
-$27.5M
52W Change
-6.9%
Annual Financials
Cash vs Debt
Where ELUT stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, ELUT finished 15.62% below its 150-day moving average ($0.96) and 16.49% below its 200-day moving average ($0.97). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ELUT overbought or oversold?
At the October 20, 2026 close, ELUT's RSI(14) was 53.8, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $19.9M in cash comfortably exceeding the $4.4M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company is burning cash, with free cash flow at -$27.5M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Revenue has pulled back from $23.8M (2022) to $12.3M (2025), a 48% decline worth watching.
With cash comfortably exceeding debt, ELUT has financial flexibility that may help navigate uncertain periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Elutia Inc. and its sector.